Strategic Intelligence for Tomorrow

  1. Home
  2. Reports Store
  3. Medical Devices
Market Analysis & Forecast

AI in Medical Imaging Market

Report Code
CM-MD-P1-1010
Base Year
2025
Study Period
2021–2025 · 2026–2035
Geographic Scope
Global
Pages
180-220
Format
PPT / WORD / EXCEL / PDF
Published
October 2026
Delivery
48 hours
Back toHealthcare Reports

Customise your request

Need this report to answer something it does not cover? Tell us the decision you are facing and we will scope the work — or point you to a study that already answers it.

info@cortexmeridian.com+971 56 483 5090

Report Scope

Report ID / SKUCM-MD-0010
Report CodeCM-MD-P1-1010
Report TypeMarket Analysis & Forecast
Base Year2025
Historical Period2021–2025
Forecast Period2026–2035
Geographic ScopeGlobal
Global CoverageYes
Regions CoveredNorth America; Europe; Asia-Pacific; Latin America; Middle East & Africa
Countries CoveredUS; Canada; Mexico; UK; Germany; France; Italy; Spain; Netherlands; Switzerland; China; India; Japan; South Korea; Australia; Brazil; Argentina; Saudi Arabia; UAE; South Africa (20 countries)
Market Size UnitUSD Billion
Volume UnitSoftware Licenses / Algorithms / Imaging Studies
Report FormatPPT / WORD / EXCEL / PDF
Page Count180-220
Delivery Timeline48 hours
Sample AvailableYes
Author / AnalystCortex Meridian Medical Devices Analyst Team
Publish DateOctober 2026
Last Updated2026-10-06

Market Overview & Definition

Market Overview & Definition

Cortex Meridian Research estimates the AI in Medical Imaging market at USD 1.8 billion in 2025 and projects it to reach approximately USD 36.5 billion by 2035, corresponding to a CAGR of 35.1%. The market is starting from a relatively small base, which explains the high growth rate, but the more important change is commercial: hospitals are moving from pilot use of single algorithms toward enterprise-wide AI orchestration, workflow integration and embedded OEM functionality.

The strongest use cases are those that reduce reporting burden, accelerate triage, improve image reconstruction or identify clinically actionable findings without adding workflow complexity. That makes integration with PACS, RIS and scanner platforms critical. Stand-alone algorithms may demonstrate clinical value, but enterprise purchasing is increasingly favoring platforms that can deploy, monitor and govern multiple AI applications at scale.

GE HealthCare’s Intelerad acquisition materially strengthens this enterprise model by combining cloud imaging infrastructure with AI orchestration. Its planned icometrix acquisition adds neurological MRI analytics, while the NVIDIA collaboration pushes AI deeper into autonomous acquisition and reconstruction. Aidoc’s USD 150 million funding round highlights investor confidence in enterprise clinical AI rather than single-use algorithms. These developments support the exceptional growth outlook because they improve distribution, interoperability and recurring subscription economics—three conditions required for AI to move from experimentation into routine deployment.

Report Description

The AI in Medical Imaging Market covers revenue generated from the defined medical-device products, related consumables and software/services where directly attached to the device workflow. The report excludes unrelated pharmaceuticals and stand-alone healthcare services. The scope is designed for manufacturers, suppliers, distributors, hospitals, diagnostic providers, investors and strategy teams evaluating demand, technology shifts, pricing and competitive opportunity.

Overall Market Dynamics

Drivers

Imaging-volume growth, radiologist shortages, demand for faster interpretation, workflow automation and improved diagnostic consistency.

Restraints / Risks

Regulatory approval, reimbursement uncertainty, algorithm bias, interoperability, cybersecurity and evidence requirements for clinical value.

Opportunities

Workflow orchestration, multimodal AI, autonomous triage, image reconstruction, opportunistic screening, cloud deployment and OEM embedding.

Strategic themes

AI/connectivity, workflow efficiency, reimbursement, regulatory approvals, recurring consumables/service revenue, and regional access expansion.

Segmentation & Scope

Segmentation & Scope

By technology: deep learning, machine learning, NLP/computer vision; by modality: CT, X-ray, MRI, ultrasound, mammography, nuclear imaging; by application: neurology, oncology, cardiology, orthopedics; by deployment: on-premise, cloud; by end user and geography.

Regional & Country Outlook

Regional & Country Outlook

COUNTRY CHAPTER COVERAGE 1. US: AI market size & forecast; AI-enabled installed base and enterprise AI deployment; AI adoption across CT/MRI/X-ray/ultrasound; reimbursement; AI/cloud adoption; GE/Siemens/Philips/Canon competition. 2. Canada: AI-enabled installed base; provincial capital budgets; imaging wait times; MRI/CT expansion; cloud imaging; procurement. 3. UK: NHS imaging capacity; scanner replacement; diagnostic backlogs; community diagnostics; AI adoption; procurement. 4. Germany: high AI-enabled installed base; premium CT/MRI; enterprise AI deployments; reimbursement; hospital digitization. 5. France: hospital imaging investment; CT/MRI/ultrasound; reimbursement; teleradiology; procurement. 6. Italy: regional imaging infrastructure; replacement demand; CT/MRI; public/private mix. 7. Spain: public hospital imaging; enterprise AI deployment; CT/MRI/ultrasound; procurement. 8. Netherlands: enterprise imaging; cloud PACS; advanced MRI/CT; AI workflow; teleradiology. 9. Switzerland: premium imaging systems; private/public hospitals; MRI/CT; AI-enabled workflows. 10. China: AI-enabled installed base expansion; domestic imaging OEMs; localization; CT/MRI demand; procurement/pricing. 11. India: diagnostic center expansion; CT/MRI/ultrasound demand; price tiers; local manufacturing; private chains. 12. Japan: aging-driven imaging demand; CT/MRI density; reimbursement; domestic OEMs; enterprise AI deployment. 13. South Korea: advanced imaging; high CT/MRI utilization; AI imaging; hospital digitization. 14. Australia: imaging center demand; reimbursement; remote radiology; CT/MRI/ultrasound replacement. 15. Brazil: private imaging chains; public access; import pricing; CT/MRI/ultrasound; distributor market. 16. Argentina: imaging AI-enabled installed base; import dependency; pricing; private hospital demand. 17. Saudi Arabia: hospital expansion; AI-enabled imaging investment; localization; AI/cloud adoption; tenders. 18. UAE: premium imaging centers; private hospitals; advanced MRI/CT; AI and cloud adoption. 19. South Africa: public/private imaging gap; CT/MRI access; replacement needs; distributor structure.

Competitive Landscape & Companies Covered

GE HealthCare; Siemens Healthineers; Philips; Canon Medical; Microsoft; Viz.ai; HeartFlow; Tempus; Aidoc; Enlitic; Nanox.AI; Butterfly Network; EchoNous

Pricing & Ecosystem

Pricing, Cost & Revenue Intelligence

Pricing intelligence benchmarks capital-system ASPs, disposable/consumable pricing, procedure-linked device pricing, service contracts, software subscriptions and regional tender dynamics where applicable. The model distinguishes capital equipment from recurring revenue and evaluates discounting, bundling, distributor margins, reimbursement sensitivity and premium technology price realization.

Value Chain & Ecosystem Analysis

The ecosystem maps component and sensor suppliers, materials vendors, device OEMs, software/AI partners, contract manufacturers, sterilization and packaging providers, distributors, hospitals/diagnostic laboratories/ASCs, clinicians, payers and regulators. The analysis identifies control points in the value chain, recurring-revenue pools, channel dependencies and partnership opportunities.

Opportunity & White-Space Analysis

A weighted opportunity model scores product segments, technologies, countries, end users and accounts using growth, market size, clinical adoption, reimbursement, competitive intensity, regulatory accessibility and margin potential. Priority white spaces include Workflow orchestration, multimodal AI, autonomous triage, image reconstruction, opportunistic screening, cloud deployment and OEM embedding.

Executive Summary

The AI in Medical Imaging market is estimated at USD 1.8 billion in 2025 and is projected to reach approximately USD 36.5 billion by 2035 at a CAGR of 35.1%. The high growth rate reflects both a small starting base and a shift from isolated algorithms toward enterprise AI platforms embedded into radiology workflows.

GE HealthCare’s Intelerad acquisition, its planned icometrix transaction and expanded NVIDIA collaboration show how major imaging vendors are building integrated AI ecosystems rather than buying stand-alone algorithms. Aidoc’s USD 150 million funding round reinforces the same trend from the specialist side. The winners are likely to be platforms that can demonstrate clinical value while solving deployment, interoperability and governance challenges at scale.

Key Takeaways

  • 2025 Cortex normalized estimate: USD 1.8 billion
  • 2035 normalized outlook: USD 36.5 billion
  • Normalized 2025–2035 CAGR: 35.1%
  • Key growth drivers: Imaging-volume growth, radiologist shortages, demand for faster interpretation, workflow automation and improved diagnostic consistency.
  • Priority opportunity areas: Workflow orchestration, multimodal AI, autonomous triage, image reconstruction, opportunistic screening, cloud deployment and OEM embedding.
  • Primary competitive set: GE HealthCare; Siemens Healthineers; Philips; Canon Medical; Microsoft; Viz.ai; HeartFlow; Tempus; Aidoc; Enlitic; Nanox.AI; Butterfly Network; EchoNous

Table of Contents

1.EXECUTIVE SUMMARY
1.1AI in Medical Imaging Market snapshot
1.22025 market size and 2035 outlook
1.3Key growth opportunities
1.4Major risks and assumptions
2.MARKET DEFINITION & SCOPE
2.1Definition
2.2Inclusion/exclusion criteria
2.3Value-chain boundary
2.4Market-sizing logic
3.MARKET DYNAMICS
3.1Drivers
3.2Restraints
3.3Opportunities
3.4Technology trends
3.5Regulatory and reimbursement impact
4.MARKET SEGMENTATION & FORECAST
4.1By product/device type
4.2By technology
4.3By application/procedure
4.4By end user
4.5By geography
5.PRICING, PROCEDURE & REVENUE INTELLIGENCE
5.1ASP ranges
5.2Procedure/test utilization
5.3Capital vs recurring revenue
5.4Service/consumable economics
6.REGIONAL & COUNTRY ANALYSIS
6.1North America
6.2Europe
6.3Asia Pacific
6.4Latin America
6.5Middle East & Africa
7.COMPETITIVE LANDSCAPE
7.1Market structure
7.2Product benchmark
7.3Technology benchmark
7.4Regulatory approvals
7.5Partnerships and M&A
7.6Company profiles
8.OPPORTUNITY & COMMERCIAL INTELLIGENCE
8.1Opportunity heat map
8.2High-growth segments
8.3White-space opportunities
8.4Target customer groups
8.5Go-to-market implications
9.METHODOLOGY
9.1Primary research
9.2Secondary research
9.3Market sizing
9.4Forecasting and validation
10.APPENDIX
6.REGIONAL & COUNTRY MARKET CHAPTERS
6.1US market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.2Canada market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.3UK market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.4Germany market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.5France market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.6Italy market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.7Spain market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.8Netherlands market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.9Switzerland market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.10China market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.11India market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.12Japan market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.13South Korea market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.14Australia market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.15Brazil market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.16Argentina market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.17Saudi Arabia market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.18UAE market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities
6.19South Africa market size, forecast, product/technology mix, demand drivers, reimbursement/procurement, competition and opportunities

List of Tables

  1. Global market value, 2021–2035
  2. Market by product/device type
  3. Market by technology
  4. Market by application/procedure
  5. Market by end user
  6. Market by region
  7. Country market sizing
  8. Installed base/procedure/test indicators
  9. ASP/pricing benchmark
  10. Company/product benchmark
  11. Opportunity attractiveness scoring

List of Figures

  1. Market size and CAGR outlook
  2. Segment attractiveness matrix
  3. Technology adoption curve
  4. Regional opportunity heat map
  5. Competitive positioning matrix
  6. Value-chain ecosystem map
  7. Pricing/revenue model
  8. Opportunity prioritization matrix

Research Methodology

Methodology

Cortex Meridian Research applies a triangulated market-sizing framework combining company disclosures, regulatory databases, procedure/test volumes, installed-base indicators, shipment and utilization data, hospital and laboratory purchasing patterns, reimbursement signals, product approvals, and primary research. Public market benchmarks are used only as external calibration points; Cortex values are normalized to the defined scope and forecast period. Forecasts consider technology adoption, procedure/test growth, replacement cycles, pricing, reimbursement, regulatory changes, and regional healthcare investment.

Data Sources & Validation

Company annual reports and investor materials; FDA, EMA and other regulatory databases; WHO and national health agencies; peer-reviewed clinical literature; procurement and reimbursement sources; hospital/laboratory statistics; trade and shipment indicators; company product portfolios; primary interviews; and public market benchmarks used for calibration.

FAQ — Buyer Questions

Q: What is the 2025 global AI in Medical Imaging market size? A: Cortex Meridian Research estimates it at approximately USD 1.8 billion.

Q: What is the 2035 market outlook? A: The normalized outlook is approximately USD 36.5 billion, based on a 35.1% CAGR assumption.

Q: What are the major growth drivers? A: Imaging-volume growth, radiologist shortages, demand for faster interpretation, workflow automation and improved diagnostic consistency.

Q: Which opportunities should suppliers prioritize? A: Workflow orchestration, multimodal AI, autonomous triage, image reconstruction, opportunistic screening, cloud deployment and OEM embedding.

Customization Options

Customization can include country-level sizing, procedure/test volumes, installed base, ASP benchmarking, hospital/lab account mapping, competitor benchmarking, product pipeline analysis, regulatory and reimbursement tracking, KOL mapping, distributor/channel assessment, and opportunity prioritization.

Need something this report does not cover?

Describe the decision you are facing. If a published study already answers it we will point you there; if not, we will scope the work and come back with timeline and cost.

CM-MD-0010 · CM-MD-P1-1010 · 180-220 pages · Published October 2026 · Cortex Meridian Medical Devices Analyst Team

Free Sample

Request a sample

Tell us where to send it. Samples include the table of contents, the methodology note and a representative section of the analysis.

Phone (Optional)
United Arab Emirates +971

This form is protected by reCAPTCHA. Google's Privacy Policy and Terms of Service apply.

We reply from insights@cortexmeridian.com within one working day. Your details are never shared.

Before You Buy

Enquire before buying

Ask before you commit. An analyst who knows the study answers — and if it does not cover what you need, they will say so rather than sell it to you.

Phone (Optional)
United Arab Emirates +971
What would you like to know?

This form is protected by reCAPTCHA. Google's Privacy Policy and Terms of Service apply.

We reply from insights@cortexmeridian.com within one working day. Sending this does not commit you to a purchase, and your details are never shared.

Custom Research

Customise your request

Tell us what you are trying to decide and we will come back with the scope, timeline and cost — or point you to a published report if one already answers it.

Phone (Optional)
United Arab Emirates +971
ReportAI in Medical Imaging Market

This form is protected by reCAPTCHA. Google's Privacy Policy and Terms of Service apply.

We reply from insights@cortexmeridian.com within one working day. Your details are never shared.

No obligation

Schedule a consultation

Thirty minutes with a senior analyst. If published research already answers your question, we will point you to it and say so.

Phone (Optional)
United Arab Emirates +971

This form is protected by reCAPTCHA. Google's Privacy Policy and Terms of Service apply.

We reply from insights@cortexmeridian.com within one working day. Your details are never shared.